E.D. Pa. (2002)
Following a Markman hearing, Judge Reed of the United States District Court for the Eastern District of Pennsylvania agreed with the construction of the claim terms set forth by Fitzpatrick on behalf of its client AstraZeneca. The Court rejected the defendant’s arguments that the claim terms should be given a more limited meaning. This decision paved the way for a finding of literal infringement.